Dosage and administration
10 drops under the tongue, 3 to 6 times per day or as directed by a health professional. Consult a physician for use in children under 12 years of age.
10 drops under the tongue, 3 to 6 times per day or as directed by a health professional. Consult a physician for use in children under 12 years of age.
Asclepias Vincetoxicum 6X, 12X, 30X, Echinacea (Angustifolia) 6X, 12X, 30X, Hypothalamus (Suis) 6X, 12X, 30X, Brain (Suis) 8X, Hepar Suis 8X, Methylcobalamin 8C, Pancreas Suis 8X, Kidney (Suis) 8X, Stomach (Suis) 8X, AACG-A 8X, 12X, 30X, 60X, 200X, AACG-B 8X, 12X, 30X, 60X, 200X, Calcarea Carbonica 12X, 30X, 60X, Gambogia 12X, 30X, 60X, Gelsemium Sempervirens 12X, 30X, 60X, Graphites 12X, 30X, 60X, Nux Vomica 12X, 30X, 60X, Phytolacca Decandra 12X, 30X, 60X, 7-KETO-DHEA (Dehydroepiandrosterone) 30X, Adenosinum Triphosphoricum Dinatrum 30X, Glucagon 30X, Insulinum 30X, Sarcolacticum Acidum 30X, Proteus (Vulgaris) 30C
For temporary relief of symptoms related to increased appetite, regulation of fat metabolism, headache, fatigue, and detoxification stress.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
If pregnant or breast-feeding, ask a health professional before use.
Tamper seal: Sealed for your protection.
Do not use if seal is broken or missing.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
10 drops under the tongue, 3 to 6 times per day or as directed by a health professional. Consult a physician for use in children under 12 years of age.
For temporary relief of symptoms related to increased appetite, regulation of fat metabolism, headache, fatigue, and detoxification stress.
demineralized water, 25% ethanol
DESBIO
NDC 43742-0365-1
hA2cg
E•V•O•L•U•T•I•O•N
WITH PATENTED ACTIVE AMINO CHAIN GROUPS
AACG-A + AACG-B
HOMEOPATHIC
1 FL OZ (30 ml)
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| 7-KETO-DEHYDROEPIANDROSTERONE | ACTIVE INGREDIENT | 2334LJD2E9 | 2 | |
| ADENOSINE TRIPHOSPHATE DISODIUM | ACTIVE INGREDIENT | 5L51B4DR1G | 2 | |
| APC-356433 | ACTIVE INGREDIENT | TX3FV9N212 | 2 | |
| APC-356434 | ACTIVE INGREDIENT | NN413ZO15B | 2 | |
| CYNANCHUM VINCETOXICUM ROOT | ACTIVE INGREDIENT | 9R858U917W | 2 | |
| ECHINACEA ANGUSTIFOLIA | ACTIVE INGREDIENT | VB06AV5US8 | 2 | |
| GAMBOGE | ACTIVE INGREDIENT | 7556HJ7587 | 2 | |
| GELSEMIUM SEMPERVIRENS ROOT | ACTIVE INGREDIENT | 639KR60Q1Q | 2 | |
| GLUCAGON | ACTIVE INGREDIENT | 76LA80IG2G | 2 | |
| GRAPHITE | ACTIVE INGREDIENT | 4QQN74LH4O | 2 | |
| INSULIN PORK | ACTIVE INGREDIENT | AVT680JB39 | 2 | |
| LACTIC ACID, L- | ACTIVE INGREDIENT | F9S9FFU82N | 2 | |
| METHYLCOBALAMIN | ACTIVE INGREDIENT | BR1SN1JS2W | 2 | |
| OYSTER SHELL CALCIUM CARBONATE, CRUDE | ACTIVE INGREDIENT | 2E32821G6I | 2 | |
| PHYTOLACCA AMERICANA ROOT | ACTIVE INGREDIENT | 11E6VI8VEG | 2 | |
| PORK BRAIN | ACTIVE INGREDIENT | 466251J72G | 2 | |
| PORK KIDNEY | ACTIVE INGREDIENT | X7BCI5P86H | 2 | |
| PORK LIVER | ACTIVE INGREDIENT | 6EC706HI7F | 2 | |
| PROTEUS VULGARIS | ACTIVE INGREDIENT | 11T9HCO30O | 2 | |
| STRYCHNOS NUX-VOMICA SEED | ACTIVE INGREDIENT | 269XH13919 | 2 | |
| SUS SCROFA HYPOTHALAMUS | ACTIVE INGREDIENT | N6R0856Z79 | 2 | |
| SUS SCROFA PANCREAS | ACTIVE INGREDIENT | 9Y3J3362RY | 2 | |
| SUS SCROFA STOMACH | ACTIVE INGREDIENT | T0920P9Z9A | 2 | |
| 7-KETO-DEHYDROEPIANDROSTERONE | ACTIVE MOIETY | 2334LJD2E9 | 2 | |
| ADENOSINE TRIPHOSPHATE | ACTIVE MOIETY | 8L70Q75FXE | 2 | |
| APC-356433 | ACTIVE MOIETY | TX3FV9N212 | 2 | |
| APC-356434 | ACTIVE MOIETY | NN413ZO15B | 2 | |
| CYNANCHUM VINCETOXICUM ROOT | ACTIVE MOIETY | 9R858U917W | 2 | |
| ECHINACEA ANGUSTIFOLIA | ACTIVE MOIETY | VB06AV5US8 | 2 | |
| GAMBOGE | ACTIVE MOIETY | 7556HJ7587 | 2 | |
| GELSEMIUM SEMPERVIRENS ROOT | ACTIVE MOIETY | 639KR60Q1Q | 2 | |
| GLUCAGON | ACTIVE MOIETY | 76LA80IG2G | 2 | |
| GRAPHITE | ACTIVE MOIETY | 4QQN74LH4O | 2 | |
| INSULIN PORK | ACTIVE MOIETY | AVT680JB39 | 2 | |
| LACTIC ACID, L- | ACTIVE MOIETY | F9S9FFU82N | 2 | |
| METHYLCOBALAMIN | ACTIVE MOIETY | BR1SN1JS2W | 2 | |
| OYSTER SHELL CALCIUM CARBONATE, CRUDE | ACTIVE MOIETY | 2E32821G6I | 2 | |
| PHYTOLACCA AMERICANA ROOT | ACTIVE MOIETY | 11E6VI8VEG | 2 | |
| PORK BRAIN | ACTIVE MOIETY | 466251J72G | 2 | |
| PORK KIDNEY | ACTIVE MOIETY | X7BCI5P86H | 2 | |
| PORK LIVER | ACTIVE MOIETY | 6EC706HI7F | 2 | |
| PROTEUS VULGARIS | ACTIVE MOIETY | 11T9HCO30O | 2 | |
| STRYCHNOS NUX-VOMICA SEED | ACTIVE MOIETY | 269XH13919 | 2 | |
| SUS SCROFA HYPOTHALAMUS | ACTIVE MOIETY | N6R0856Z79 | 2 | |
| SUS SCROFA PANCREAS | ACTIVE MOIETY | 9Y3J3362RY | 2 | |
| SUS SCROFA STOMACH | ACTIVE MOIETY | T0920P9Z9A | 2 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 43742-0365 | 43742-0365-1 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ALCOHOL | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| ALCOHOL | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| c05fad08-b740-4118-b5d5-6a6e572e0a88 | d7abdd03-9264-48dc-b0ba-b92f3ed94858 | 2017-04-18 | Warnings | c05fad08-b740-4118-b5d5-6a6e572e0a88 d7abdd03-9264-48dc-b0ba-b92f3ed94858 |
Adverse event summaries are temporarily unavailable. Other product information remains available.